SRHHL

Kurnool, India Founded: 2005 • Age: 21 yrs Listed
Speciality chemicals and alkalies are manufactured and exported by SRHHL.

About SRHHL

SRHHL is a publicly listed company based in Kurnool (India) founded in 2005 by T G Venkatesh. Speciality chemicals and alkalies are manufactured and exported by SRHHL. The company has 41 employees. Its Indian entity Sree Rayalaseema Hi-Strength Hypo Limited reported revenue of β‚Ή722 Cr. SRHHL offers products and services including Sulphuric Acid, Hydrochloric Acid, Chlorosulphonic Acid, Stable Bleaching Powder, and Sodium Methoxide Solution. Its focus areas include Chemicals and Materials, Diversified Chemicals and Diversified.

Company details

SRHHL was established in 2005 by T G Venkatesh in Kurnool, India. Speciality chemicals and alkalies are produced and exported from this location. Operations center on the chemical manufacturing sector, with a focus on industrial applications. Products are distributed to domestic and international markets through export channels. The company maintains its headquarters in Kurnool, supporting regional chemical production needs.

  • Headquarters Kurnool, India
  • Employees 41
  • Founders T G Venkatesh
  • Stage Public
  • Sectors
    Chemicals & Materials
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website srhhl.com
  • Social LinkedIn
  • Legal Name Sree Rayalaseema Hi-Strength Hypo Limited
  • Date of Incorporation 28 Mar, 2005
  • Jurisdiction Kurnool, Andhra Pradesh, India
Key Metrics
  • Market Cap
    ₹846 Cr

    SRHHYPOLTD · NSE

  • Share Price
    ₹492.90

    -0.75% today

  • Revenue
    ₹667 Cr

    FY 2025-26 · +4.6% YoY

  • EBITDA
    ₹74.92 Cr

    Margin 11.2%

  • Net Profit
    ₹99.01 Cr

    FY 2025-26 · +7.1% YoY

  • P/E (TTM)
    8.5x

    P/B 0.9x

  • Employee Count
    41

Products & Services of SRHHL

SRHHL offers a comprehensive portfolio of products and services, including Sulphuric Acid, Hydrochloric Acid, Chlorosulphonic Acid, Stable Bleaching Powder, and Sodium Methoxide Solution.

Sulphuric Acid
Chemical

Acid used in industrial processes for manufacturing and refining.

Hydrochloric Acid
Chemical

Acid applied in cleaning and chemical production industries.

Chlorosulphonic Acid
Chemical

Acid utilized for sulfonation in pharmaceutical and dye sectors.

Stable Bleaching Powder
Chemical

Powder for water treatment and disinfection purposes.

Sodium Methoxide Solution
Chemical

Solution used as a catalyst in biodiesel and organic synthesis.

Board of directors of Sree Rayalaseema Hi-Strength Hypo Limited (SRHHL)

Sree Rayalaseema Hi-Strength Hypo Limited is the primary company behind SRHHL. The board of Sree Rayalaseema Hi-Strength Hypo Limited currently have 6 directors; the longest-serving is Gurunatha Reddy Hiregoudara, appointed in 2015. 13 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Gurunatha Reddy Hiregoudara
DIN 07211326
Director15 Jun 201511 yrs 4 moSree Rayalaseema Hi-Strength Hypo Limited
Agadi Kailashnath
DIN 03017003
Director30 May 201610 yrs 5 moSree Rayalaseema Hi-Strength Hypo Limited
Rukmangada Triveni
DIN 09045405
Director13 Feb 20215 yrs 8 moSree Rayalaseema Hi-Strength Hypo Limited
Satyam Gadwal
DIN 09762624
Director13 Oct 20224 yrsSree Rayalaseema Hi-Strength Hypo Limited
Shilpa Bharath Tumbalam Gooty
DIN 01895414
Managing Director26 Jun 20242 yrs 4 moSree Rayalaseema Hi-Strength Hypo Limited
Kamma Edlapalli Krishna
DIN 11239076
Director14 Aug 20251 yr 2 moSree Rayalaseema Hi-Strength Hypo Limited

People of SRHHL

1 people are tracked at SRHHL (1 in leadership); the tracked headcount is 41.

NameRoleGroup
T G Venkatesh
FounderLeadership
Premium access

Complete people profiles for SRHHL

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of SRHHL

SRHHL is a publicly listed company on the NSE with ticker symbol SRHHYPOLTD in India, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date11 May 2007
  • Listed onNSE: SRHHYPOLTD
  • Listed entitySree Rayalaseema Hi-Strength Hypo Limited
  • Exchange sectorProcess industries

Financials of SRHHL

Exchange-reported figures of Sree Rayalaseema Hi-Strength Hypo Limited, the listed company behind SRHHL (NSE: SRHHYPOLTD).

Financial Highlights

FY 2025-26 Β· Consolidated
Revenue
₹667 Cr
+4.6% YoY
EBITDA
₹74.92 Cr
-15.8% YoY
Profit After Tax
₹99.01 Cr
+7.1% YoY
Net Worth
-
Total Assets
-
Total Debt
-

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue6676388661,6501,267911689
Revenue growth+4.6%-26.4%-47.5%+30.2%+39.1%+32.2%-
EBITDA74.9288.9899.70180149130102
EBITDA margin+11.2%+14.0%+11.5%+10.9%+11.7%+14.3%+14.8%
Profit before tax12111910719013780.8245.46
Net profit99.0192.4787.1214210360.5537.91
Net profit margin+14.8%+14.5%+10.1%+8.6%+8.1%+6.7%+5.5%
EPS (β‚Ή)53.2452.4746.0689.8759.8835.2922.08
Balance sheet
Total assets-954818775603463372
Net worth-918801751570388312
Total debt-15.7412.9219.1728.3671.5157.23
Cash & bank-37433422911313986.43
Net working capital-522476431297258180
Cash flow
Cash from operations-65.4814014159.7570.5699.31
Cash from investing-(8.23)(19.99)(112)(1.17)(115)(37.60)
Cash from financing-(17.58)(16.83)(16.65)(51.32)10.16(21.84)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue211163141182180160138170
Revenue growth (YoY)+17.0%+1.7%+2.0%+7.1%+6.9%---
Other income9.8717.9019.407.1010.3915.3312.569.13
EBITDA26.357.7617.0426.9523.1714.5619.8028.95
EBITDA margin+12.5%+4.8%+12.1%+14.8%+12.9%+9.1%+14.3%+17.0%
Depreciation1.811.821.811.801.801.901.841.92
Interest0.500.420.410.420.420.690.370.32
Profit before tax33.9123.4234.2231.8331.3427.3030.1535.84
Tax9.173.3710.478.548.925.318.6010.54
Net profit24.7420.0523.7523.2922.4221.9921.5525.30
EPS (β‚Ή)14.5311.83(14.04)13.5713.0612.8112.5614.74
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue6676388661,6501,267911689
Revenue growth+4.6%-26.4%-47.5%+30.2%+39.1%+32.2%-
EBITDA75.7492.5599.79180149130102
EBITDA margin+11.4%+14.5%+11.5%+10.9%+11.7%+14.3%+14.8%
Profit before tax12312410919013780.8545.46
Net profit10395.1088.5314210360.5837.91
Net profit margin+15.4%+14.9%+10.2%+8.6%+8.1%+6.7%+5.5%
EPS (β‚Ή)53.9753.9946.8589.9059.8835.3022.09
Balance sheet
Total assets-943812771603463372
Net worth-922802751570388312
Total debt-15.454.9115.9728.0671.5157.23
Cash & bank-37333422911313986.42
Net working capital-517494441297258180
Cash flow
Cash from operations-87.7513213160.1170.5499.31
Cash from investing-(40.44)(7.89)(98.62)(1.20)(115)(37.61)
Cash from financing-(8.25)(21.63)(19.96)(51.62)10.16(21.84)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue211163141182180160138170
Revenue growth (YoY)+17.0%+1.7%+2.0%+7.1%+6.9%---
Other income9.8817.9219.457.0810.4015.3312.568.70
Total expenses185155124155157146117140
EBITDA26.377.8417.1527.0123.7414.8721.3629.79
EBITDA margin+12.5%+4.8%+12.1%+14.8%+13.2%+9.3%+15.4%+17.5%
Depreciation1.411.411.411.401.401.491.431.52
Interest0.500.420.410.420.420.690.370.49
Profit before tax34.3423.9334.7832.2732.3228.0232.1236.48
Tax9.173.3710.477.908.925.318.6010.54

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 10 Nov 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue211163141182180160138170
Revenue growth (YoY)+17.0%+1.7%+2.0%+7.1%+6.9%---
Other income9.8717.9019.407.1010.3915.3312.569.13
EBITDA26.357.7617.0426.9523.1714.5619.8028.95
EBITDA margin+12.5%+4.8%+12.1%+14.8%+12.9%+9.1%+14.3%+17.0%
Depreciation1.811.821.811.801.801.901.841.92
Interest0.500.420.410.420.420.690.370.32
Profit before tax33.9123.4234.2231.8331.3427.3030.1535.84
Tax9.173.3710.478.548.925.318.6010.54
Net profit24.7420.0523.7523.2922.4221.9921.5525.30
EPS (β‚Ή)14.5311.83(14.04)13.5713.0612.8112.5614.74
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue6676388661,6501,267911689
Revenue growth+4.6%-26.4%-47.5%+30.2%+39.1%+32.2%-
Other income54.7939.4722.1534.1110.686.633.92
Total expenses5925497661,4701,119781587
Employee cost0.0034.3735.1438.8128.7425.4522.53
EBITDA74.9288.9899.70180149130102
EBITDA margin+11.2%+14.0%+11.5%+10.9%+11.7%+14.3%+14.8%
Depreciation7.247.3210.6019.3519.2350.6150.27
Interest1.681.983.984.753.215.4810.16
Profit before tax12111910719013780.8245.46
Tax30.6531.6828.3136.1734.2020.277.54
Net profit99.0192.4787.1214210360.5537.91
Net profit margin+14.8%+14.5%+10.1%+8.6%+8.1%+6.7%+5.5%
EPS (β‚Ή)53.2452.4746.0689.8759.8835.2922.08
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital-17.1617.1617.1617.1617.1617.16
Reserves & surplus-901783734553371294
Shareholders' funds (net worth)-918801751570388312
Minority interest-14.470.070.160.030.000.00
Secured loans-1.618.0111.9019.1061.3445.38
Unsecured loans-14.134.917.279.2610.1711.85
Total debt-15.7412.9219.1728.3671.5157.23
Total liabilities-954818775603463372
Assets
Gross block-477470437466429406
Net block-135128105130134161
Capital work in progress-0.000.0013.610.050.443.05
Investments-34925326816450.3418.43
Inventories-39.7331.6912614439.7136.71
Sundry debtors-10310714913296.6082.03
Cash & bank balances-37433422911313986.43
Loans & advances-64.4956.7650.1992.3639.2942.45
Total current assets-581529554482314248
Total current liabilities-59.4253.0312318555.9068.11
Net working capital-522476431297258180
Total assets-954818775603463372
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash-3292262146.9941.651.78
Net cash from operating activities-65.4814014159.7570.5699.31
Net cash from investing activities-(8.23)(19.99)(112)(1.17)(115)(37.60)
Net cash from financing activities-(17.58)(16.83)(16.65)(51.32)10.16(21.84)
Net change in cash-39.6710312.517.26(34.66)39.87
Closing cash-37433422911313986.43
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+4.6%-26.4%-47.5%+30.2%+39.1%+32.2%-
EBITDA growth-15.8%-10.8%-44.7%+21.3%+14.2%+27.8%-
PBT growth+1.4%+11.1%-43.7%+39.0%+69.5%+77.8%+425.6%
Net income growth+7.1%+6.1%-38.8%+38.5%+69.7%+59.7%-
Revenue CAGR (3Y)-26.1%-20.5%-1.7%+33.8%+97.6%+35.8%-
EBITDA CAGR (3Y)-25.4%-15.7%-8.5%+21.0%+89.6%+44.8%-
Profitability & leverage
Net income margin+13.5%+13.7%+9.1%+9.4%+8.1%+6.7%+5.5%
Return on capital employed-+13.8%+15.3%+28.3%+26.3%+20.7%+15.0%
Return on net worth-+10.2%+11.2%+23.4%+21.5%+17.3%+12.2%
Debt / equity-0.020.020.040.100.180.18
Long-term debt / equity-0.010.010.010.020.030.03
Interest cover2.482.424.472.952.486.8819.65
Efficiency & per share
Fixed asset turnover-1.351.913.652.832.181.70
Inventory turnover-17.8611.0012.2313.8023.8418.77
Debtors turnover-6.076.7711.7411.0810.208.40
EPS (β‚Ή)53.2452.4746.0689.8759.8835.2922.08
Dividend per share (β‚Ή)3.003.003.004.003.503.002.50
Book value per share (β‚Ή)0.00534.98466.43437.48332.24226.03181.51
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue211163141182180160138170
Revenue growth (YoY)+17.0%+1.7%+2.0%+7.1%+6.9%---
Other income9.8817.9219.457.0810.4015.3312.568.70
Total expenses185155124155157146117140
EBITDA26.377.8417.1527.0123.7414.8721.3629.79
EBITDA margin+12.5%+4.8%+12.1%+14.8%+13.2%+9.3%+15.4%+17.5%
Depreciation1.411.411.411.401.401.491.431.52
Interest0.500.420.410.420.420.690.370.49
Profit before tax34.3423.9334.7832.2732.3228.0232.1236.48
Tax9.173.3710.477.908.925.318.6010.54
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue6676388661,6501,267911689
Revenue growth+4.6%-26.4%-47.5%+30.2%+39.1%+32.2%-
Other income54.8639.4723.5034.1110.666.633.92
Total expenses5915457661,4701,118781587
Employee cost0.0034.1435.0738.7828.7425.4522.53
EBITDA75.7492.5599.79180149130102
EBITDA margin+11.4%+14.5%+11.5%+10.9%+11.7%+14.3%+14.8%
Depreciation5.625.7010.5819.3519.2350.6150.27
Interest1.681.983.984.753.215.4810.16
Profit before tax12312410919013780.8545.46
Tax30.6531.6828.3136.1734.2020.277.54
Net profit10395.1088.5314210360.5837.91
Net profit margin+15.4%+14.9%+10.2%+8.6%+8.1%+6.7%+5.5%
EPS (β‚Ή)53.9753.9946.8589.9059.8835.3022.09
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital-17.1617.1617.1617.1617.1617.16
Reserves & surplus-905785734553371294
Shareholders' funds (net worth)-922802751570388312
Secured loans-1.320.008.7018.8061.3445.38
Unsecured loans-14.134.917.279.2610.1711.85
Total debt-15.454.9115.9728.0671.5157.23
Total liabilities-943812771603463372
Assets
Gross block-453446437443429406
Net block-112103105130134161
Capital work in progress-0.000.000.000.000.443.05
Investments-36625326816450.4518.44
Inventories-39.1531.5612614439.7136.71
Sundry debtors-10310714913296.6082.03
Cash & bank balances-37333422911313986.42
Loans & advances-60.4374.1459.9692.3639.2942.45
Total current assets-576546563482314248
Total current liabilities-59.1652.5912218555.8368.11
Net working capital-517494441297258180
Total assets-943812771603463372
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash-3292262146.8641.641.78
Net cash from operating activities-87.7513213160.1170.5499.31
Net cash from investing activities-(40.44)(7.89)(98.62)(1.20)(115)(37.61)
Net cash from financing activities-(8.25)(21.63)(19.96)(51.62)10.16(21.84)
Net change in cash-39.0610312.367.28(34.78)39.86
Closing cash-37333422911313986.42
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+4.6%-26.4%-47.5%+30.2%+39.1%+32.2%-
EBITDA growth-18.2%-7.3%-44.7%+21.3%+14.2%+27.8%-
PBT growth-0.8%+14.4%-42.9%+39.1%+69.4%+77.9%+7.7%
Net income growth+8.1%+7.4%-37.8%+38.6%+69.6%+59.8%-
Revenue CAGR (3Y)-26.1%-20.5%-1.7%+33.8%+21.8%+18.6%+23.4%
EBITDA CAGR (3Y)-25.1%-14.6%-8.5%+21.0%+14.8%+41.7%+30.7%
Profitability & leverage
Net income margin+13.9%+14.5%+9.3%+9.4%+8.1%+6.7%+5.5%
Return on capital employed-+14.4%+14.2%+28.4%+26.3%+20.7%+14.8%
Return on net worth-+10.8%+10.4%+23.4%+21.5%+17.3%+11.9%
Debt / equity-0.010.010.030.100.180.17
Long-term debt / equity-0.010.010.010.020.030.03
Interest cover2.402.284.462.952.486.8819.65
Efficiency & per share
Fixed asset turnover-1.421.963.752.912.181.73
Inventory turnover-18.0411.0112.2313.8023.8418.68
Debtors turnover-6.076.7711.7411.0810.208.11
EPS (β‚Ή)53.9753.9946.8589.9059.8835.3022.09
Dividend per share (β‚Ή)3.003.003.004.003.503.002.50
Book value per share (β‚Ή)0.00537.34467.27437.55332.26226.05181.51

Web traffic of SRHHL

The website of SRHHL (srhhl.com) receives about 6.3K visits a month.

  • Monthly visits
    6.3K

    ▲ 164.5% vs previous month

Top companies in Core & Diversified Chemicals

3 companies that operate in the same segment as SRHHL (Core & Diversified Chemicals) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Manufacturer of fertilizers, industrial chemicals, crop nutrition products, and real estate
1979Pune, Maharashtra, IndiaUSD 1.21 B1,020
Specialty chemicals are manufactured through integrated R&D and production processes.
2023Bengaluru, Karnataka, IndiaUSD 72.97 MUSD 23.86 M
Manufactures coal tar and basic industrial chemicals.
1987Kolkata, West Bengal, IndiaUSD 24 MUSD 515.01 M1,161
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Srhhl

Premium access

Complete news archive for SRHHL

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about SRHHL

SRHHL was founded in 2005.

SRHHL is headquartered in Kurnool, India. It is registered at Kurnool, Andhra Pradesh, India.

SRHHL has 41 employees.

The primary company behind SRHHL, Sree Rayalaseema Hi-Strength Hypo Limited, reported revenue of β‚Ή722 Cr for FY 2026, up 5% year on year.

SRHHL was established in 2005 by T G Venkatesh in Kurnool, India. Speciality chemicals and alkalies are produced and exported from this location. Operations center on the chemical manufacturing sector, with a focus on industrial applications. Products are distributed to domestic and international markets through export channels. The company maintains its headquarters in Kurnool, supporting regional chemical production needs.

SRHHL offers Sulphuric Acid, Hydrochloric Acid, Chlorosulphonic Acid, Stable Bleaching Powder, and Sodium Methoxide Solution.

Yes, SRHHL is publicly traded on NSE under the ticker symbol SRHHYPOLTD.

SRHHL operates through Sree Rayalaseema Hi-Strength Hypo Limited.

The legal entities of SRHHL currently have 8 directors, including Shilpa Bharath Tumbalam Gooty, Agadi Kailashnath, Gurunatha Reddy Hiregoudara and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available